Publications by authors named "Max I Hamburger"
Introduction: The aim of this study was to compare the response between subsequent use of anti-tumor necrosis factor α (anti-TNF) agents and biologic disease-modifying anti-rheumatic drugs (bDMARD) with other mechanism of action (MOA) in rheumatoid arthritis (RA) patients with history of anti-TNF treatment as their first bDMARD.
Methods: A retrospective chart review was conducted at eight community-based rheumatology practices in the United States in 2012. Routine Assessment of Patient Index Data 3 (RAPID3) response was measured by comparing baseline and 6-month scores.
Objective: To determine the variables underlying clinical decisions made by rheumatologists when treating patients with rheumatoid arthritis (RA), and to determine the effect of an educational seminar on the use of quantitative disease activity measurements in clinical practice in this population of physicians.
Methods: Practicing rheumatologists were surveyed on the variables affecting their clinical management of patients with RA by questionnaire. Physicians were divided into 2 groups: the first comprised attenders (Group A) to an educational seminar in the use of the quantitative disease activity measurements in patient management, while the second group comprised nonattenders (Group NA).
Intra-articular hyaluronans: a review of product-specific safety profiles.
Semin Arthritis Rheum
April 2003
Article Synopsis
- Intra-articular hyaluronans (HAs) are injections used to help relieve knee pain from osteoarthritis (OA).
- There are three main types approved by the FDA: Hyalgan, Supartz, and Synvisc, which are made from rooster combs, but Synvisc is modified to work differently.
- Most people tolerate these injections well, with only mild pain or swelling at the injection site reported, but there can be some rare side effects with Synvisc, including allergic reactions.